---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-025702"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2025-08-27T23:59:59+00:00"
generated_at: "2026-05-17T09:40:54.765998+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Qualigen restructures $4.45M Marizyme note, secures assets, pro forma equity positive

## Summary
- Amended Note principal $4,451,462 with 18% interest, due Aug 21, 2026; includes $216K new advance.
- Marizyme granted security interest in substantially all assets under new Security Agreement.
- Pro forma balance sheet shows cash $4.59M, total equity $3.24M; company reports equity > $2.5M.
- Forbearance on demand for 365 days; default rate increases 5% per annum.

## SEC filing metadata
- accession: 0001641172-25-025702
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2025-08-27T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000164117225025702/0001641172-25-025702-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000164117225025702/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-025702
- JSON: https://secwatch.observer/filing/0001641172-25-025702.json
- Plain text: https://secwatch.observer/filing/0001641172-25-025702.txt

## Key facts
- Debt Financings
  AIxCrypto Holdings, Inc. amended loan of $4,451,462.18 with Marizyme, Inc. at 18% per annum maturing August 21, 2026.
  - Instrument: loan
  - Principal: $4,451,462.18
  - Counterparty: Marizyme, Inc.
  - Rate: 18% per annum
  - Maturity: August 21, 2026
  - Event: amendment
  source text: The Amended Note has a principal balance of $4,451,462.18, which represents (i) the outstanding balance of the Prior Note, (ii) accrued and unpaid interest thereon, and (iii) an additional advance of $216,000 made by the Company to Marizyme on the date of the Amended Note. The Amended Note bears interest at a rate of 18% per annum, with all accrued interest and the full principal balance due in a single balloon payment on August 21, 2026 (subject to earlier demand upon an event of default).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000164117225025702/0001641172-25-025702-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.